Postoperative complications after gastrointestinal pediatric surgical procedures: outcomes and socio-demographic risk factors.

Background: Several socio-demographic characteristics are associated with complications following certain pediatric surgical procedures. In this comprehensive study, we sought to determine socio-demographic risk factors and resource utilization of children with complications after common pediatric surgical procedures.

Methods: We performed a population-based cohort study utilizing the 2016 Healthcare Cost and Use Project Kids' Inpatient Database (KID) to identify and characterize pediatric patients (age 0-21 years) in the United States with common inpatient pediatric gastrointestinal surgical procedures: appendectomy, cholecystectomy, colonic resection, pyloromyotomy and small bowel resection.

Safety and efficacy of tranexamic acid in bleeding paediatric trauma patients: a systematic review protocol.

Introduction: Trauma is the leading cause of death among children aged 1-18. Studies indicate that better control of bleeding could potentially prevent 10-20% of trauma-related deaths. The antifibrinolytic agent tranexamic acid (TxA) has shown promise in haemorrhage control in adult trauma patients.

A contemporary prediction rule for esophageal atresia (EA) and tracheo-esophageal fistula (TEF).

Background/purpose: Existing prediction models for tracheo-esophageal fistula (TEF) and esophageal atresia (EA) are derived from small single-institution populations treated over long periods. A prediction rule developed in a contemporary, multicenter cohort is important for counseling, tailoring therapy, and benchmarking outcomes.

Methods: Data were obtained from the 2003, 2006, and 2009 editions of the HCUP Kids' Inpatient Database.

A clinical prediction rule for the severity of congenital diaphragmatic hernias in newborns.

Background: Congenital diaphragmatic hernia (CDH) is a condition with a highly variable outcome. Some infants have a relatively mild disease process, whereas others have significant pulmonary hypoplasia and hypertension. Identifying high-risk infants postnatally may allow for targeted therapy.